WX [WuXi PharmaTech (Cayman)] CT ORDER: (Original Filing)
[]
BSPM [Biostar Pharmaceuticals,] NT 10-K: (Original Filing)
[FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x o o o o o December 31, 2012 For Period Ended: o o o o o For the Transition Period Ended: ________________________ Read attached instruction sheet before preparing form. Please print or type. Nothing in this form shall benstrued to imply that themmission has verified any]
BSPM [Biostar Pharmaceuticals,] NT 10-K: FORM 12b-25 NOTIFICATION OF LATE FILING (Check One):
[FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x o o o o o December 31, 2012 For Period Ended: o o o o o For the Transition Period Ended: ________________________ Read attached instruction sheet before preparing form. Please print or type. Nothing in this form shall benstrued to imply that themmission has verified any]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[SUPPLEMENTAL AGREEMENT TO SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND FORMER SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. Supplemental Agreement Transferee Party A: Shaanxi Aoxing Pharmaceuticals Co., Ltd. (hereinafter referred to as “ Transferors Party B: All Former Shareholders of Shaanxi Weinan Huaren Pharmaceuticals Co., Ltd. who]
BSPM [Biostar Pharmaceuticals,] 8-K: SUPPLEMENTAL AGREEMENT TO SHARE TRANSFER CONTRACT OF SHAANXI
[SUPPLEMENTAL AGREEMENT TO SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND FORMER SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. Supplemental Agreement Transferee Party A: Shaanxi Aoxing Pharmaceuticals Co., Ltd. (hereinafter referred to as “ Transferors Party B: All Former Shareholders of Shaanxi Weinan Huaren Pharmaceuticals Co., Ltd. who]
TPI [TIANYIN PHARMACEUTICAL] 10-K/A: (Original Filing)
[FORM 10-K/A (Amendment No. 1) x FOR THE FISCAL YEAR ENDED JUNE 30, 2012 o FOR THE TRANSITION PERIOD FROM TO TIANYIN PHARMACEUTICAL CO., INC. Delaware (State or other jurisdiction of incorporation) (I.R.S. Employer Identification or Organization No.) 23rd Floor, UnionsunYangkuo Plaza No.2, Block 3, Renmin Road South, Chengdu, 610041 P. R. China 0086-028-86154737 and principal place of business) Securities] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this annual report on Form 10-K/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James J. Tong, certify that: 1. I have reviewed this annual report on Form 10-K/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James J. Tong Chief Financial Officer]
TPI [TIANYIN PHARMACEUTICAL] 10-K/A: FORM 10-K/A (Amendment No. 1) x FOR THE
[FORM 10-K/A (Amendment No. 1) x FOR THE FISCAL YEAR ENDED JUNE 30, 2012 o FOR THE TRANSITION PERIOD FROM TO TIANYIN PHARMACEUTICAL CO., INC. Delaware (State or other jurisdiction of incorporation) (I.R.S. Employer Identification or Organization No.) 23rd Floor, UnionsunYangkuo Plaza No.2, Block 3, Renmin Road South, Chengdu, 610041 P. R. China 0086-028-86154737 and principal place of business) Securities] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this annual report on Form 10-K/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James J. Tong, certify that: 1. I have reviewed this annual report on Form 10-K/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James J. Tong Chief Financial Officer]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[SUPPLEMENTALREEMENT TO SHARE TRANSFERNTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS AND FORMER SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS Supplementalreement Transferee Party A: Shaanxi Aoxing Pharmaceuticals (hereinafter referred to Transferors Party B:l Former Shareholders of Shaanxi Weinan Huaren Pharmaceuticals who are listed in Appendix I of thisreement (hereinafter referred to]
BSPM [Biostar Pharmaceuticals,] 8-K: SUPPLEMENTALREEMENT TO SHARE TRANSFERNTRACT OF SHAANXI WEINAN HUAREN
[SUPPLEMENTALREEMENT TO SHARE TRANSFERNTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS AND FORMER SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS Supplementalreement Transferee Party A: Shaanxi Aoxing Pharmaceuticals (hereinafter referred to Transferors Party B:l Former Shareholders of Shaanxi Weinan Huaren Pharmaceuticals who are listed in Appendix I of thisreement (hereinafter referred to]
